(Q64970354)

title

Alpha-globulins suppress human leukocyte tumor necrosis factor secretion. (English)

1 reference

2 July 2019

2

Dorr RT

1 reference

2 July 2019

author name string

Scuderi P

1

1 reference

2 July 2019

Liddil JD

3

1 reference

2 July 2019

Finley PR

4

1 reference

2 July 2019

Meltzer P

5

1 reference

2 July 2019

Raitano AB

6

1 reference

2 July 2019

Rybski J

7

1 reference

2 July 2019

publication date

1 May 1989

1 reference

2 July 2019

European Journal of Immunology

published in

1 reference

2 July 2019

volume

19

1 reference

2 July 2019

page(s)

939-942

1 reference

2 July 2019

issue

5

1 reference

2 July 2019

Tumor necrosis factor (TNF).

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Requirement for the continual presence of lipopolysaccharide for production of tumor necrosis factor by thioglycollate-induced peritoneal murine macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Identification of individual tumor necrosis factor/cachectin-producing cells after lipopolysaccharide induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Recombinant interferon-gamma stimulates the production of human tumor necrosis factor in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Regulation of tumor necrosis factor (TNF) expression: interferon-gamma enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

In vitro induction of hepatocyte synthesis of the acute phase reactant mouse serum amyloid P-component by macrophages and IL 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Raised serum levels of tumour necrosis factor in parasitic infections.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

The occurrence of common inhibitors of trypsin and of leucocyte neutral proteinase in human serum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

p-Nitrophenyl-p'-guanidinobenzoate HCl: a new active site titrant for trypsin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

An alternative regulatory pathway of the acute phase response: the role of fibroblast-derived interferon-beta 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Induction of rat acute-phase proteins by interleukin 6 in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190523

7 January 2021

Identifiers

DOI

10.1002/EJI.1830190523

1 reference

2 July 2019

1 reference

2 July 2019